HEADER RECEPTOR 22-NOV-01 1GQB TITLE HUMAN MIR-RECEPTOR, REPEAT 11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATION-INDEPENDENT MANNOSE-6-PHOSPHATE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: IGF-II-BINDING DOMAIN, REPEAT 11, RESIDUES 1508-1650; COMPND 5 SYNONYM: MANNOSE-6-PHOSPHATE RECEPTOR, INSULIN-LIKE GROWTH-FACTOR II COMPND 6 RECEPTOR, CI MAN-6-P RECEPTOR, CI-MPR, 300 KDA MANNOSE 6-PHOSPHATE COMPND 7 RECEPTOR, MPR 300; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: BHK-21; SOURCE 6 ORGAN: KIDNEY; SOURCE 7 CELL: FIBROBLAST; SOURCE 8 EXPRESSION_SYSTEM: CRICETINAE GEN. SP.; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 36483 KEYWDS RECEPTOR, MIR-RECEPTOR, IGF-II RECEPTOR, TRANSPORT, GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.VON BUELOW,M.DAUTER,Z.DAUTER,K.R.RAJASHANKAR,S.GRIMME,B.SCHMIDT, AUTHOR 2 K.VON FIGURA,I.USON REVDAT 6 06-NOV-24 1GQB 1 REMARK REVDAT 5 22-MAY-19 1GQB 1 REMARK REVDAT 4 30-JAN-19 1GQB 1 REMARK ATOM REVDAT 3 24-FEB-09 1GQB 1 VERSN REVDAT 2 05-APR-05 1GQB 1 JRNL DBREF REVDAT 1 05-DEC-02 1GQB 0 JRNL AUTH I.USON,B.SCHMIDT,R.VON BUELOW,S.GRIMME,K.VON FIGURA, JRNL AUTH 2 M.DAUTER,K.R.RAJASHANKAR,Z.DAUTER,G.M.SHELDRICK JRNL TITL LOCATING THE ANOMALOUS SCATTERER SUBSTRUCTURES IN HALIDE AND JRNL TITL 2 SULFUR PHASING JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 59 57 2003 JRNL REFN ISSN 0907-4449 JRNL PMID 12499540 JRNL DOI 10.1107/S090744490201884X REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.209 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.208 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1340 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 26877 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.194 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.194 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1178 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 23481 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1992 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 145 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2132.3 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 12 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 8659 REMARK 3 NUMBER OF RESTRAINTS : 10445 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 ANGLE DISTANCES (A) : 0.021 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.042 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.028 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.032 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.035 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.017 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.055 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-2 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINED OCCUPANCY FOR ALTERNATIVE REMARK 3 DISORDERED SITES REMARK 4 REMARK 4 1GQB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-NOV-01. REMARK 100 THE DEPOSITION ID IS D_1290009022. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X9B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.919 REMARK 200 MONOCHROMATOR : SI 111 DOUBLE REMARK 200 OPTICS : FLAT BENT MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29383 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.11200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SHELXD, SHARP, DM REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: ALSO SOLVED THROUGH BR-SAD WITH THESE DATA REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PRECIPITANT: 0.2 M AMMONIUM ACETATE, REMARK 280 0.1 M CACODYLATE PH 5, 28% PEG 4000. PROTEIN SOLUTION: 8 MG/ML REMARK 280 IN 10 MM TRIS-HCL PH7.5, 150 MM VAPOUR DIFFUSION, HANGING DROPS, REMARK 280 1:1 RATIO., PH 5.60, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 51.21300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.53000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 51.21300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.53000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REPONSIBLE FOR THE TRANSPORT OF PHOSPHORYLATED LYSOSOMAL REMARK 400 FROM CELL SURFACE AND GOLGI COMPLEX TO LYSOSOMES. REMARK 400 THIS ENTRY CONTAINS THE SAME COMPOUND AS 1E6F IN A REMARK 400 DIFFERENT CRYSTAL FORM. BOTH CRYSTALS GROW UNDER THE SAME REMARK 400 CONDITIONS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 SER A 3 REMARK 465 ASN A 4 REMARK 465 GLU A 5 REMARK 465 ALA A 111 REMARK 465 GLY A 112 REMARK 465 PRO A 113 REMARK 465 THR A 114 REMARK 465 GLN A 141 REMARK 465 ALA A 142 REMARK 465 THR A 143 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 SER B 3 REMARK 465 ASN B 4 REMARK 465 GLU B 5 REMARK 465 HIS B 6 REMARK 465 ALA B 111 REMARK 465 GLY B 112 REMARK 465 PRO B 113 REMARK 465 THR B 114 REMARK 465 GLN B 141 REMARK 465 ALA B 142 REMARK 465 THR B 143 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 64 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 36 -160.35 53.08 REMARK 500 PRO A 92 94.45 -60.56 REMARK 500 ASP B 8 31.15 -149.15 REMARK 500 SER B 36 -153.96 54.53 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A1142 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A1143 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR A1144 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B1141 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B1142 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B1143 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B1144 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B1145 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BR B1146 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E6F RELATED DB: PDB REMARK 900 HUMAN MIR-RECEPTOR, REPEAT 11 REMARK 900 RELATED ID: 1GP0 RELATED DB: PDB REMARK 900 STRUCTURE OF A FUNCTIONAL IGF2R FRAGMENT DETERMINED FROM ANOMALOUS REMARK 900 SCATTERING OF SULPHUR REMARK 900 RELATED ID: 1GP3 RELATED DB: PDB REMARK 900 STRUCTURE OF A FUNCTIONAL IGF2R FRAGMENT DETERMINED FROM ANOMALOUS REMARK 900 SCATTERING OF SULPHUR DBREF 1GQB A 1 143 UNP P11717 MPRI_HUMAN 1508 1650 DBREF 1GQB B 1 143 UNP P11717 MPRI_HUMAN 1508 1650 SEQRES 1 A 143 MET LYS SER ASN GLU HIS ASP ASP CYS GLN VAL THR ASN SEQRES 2 A 143 PRO SER THR GLY HIS LEU PHE ASP LEU SER SER LEU SER SEQRES 3 A 143 GLY ARG ALA GLY PHE THR ALA ALA TYR SER GLU LYS GLY SEQRES 4 A 143 LEU VAL TYR MET SER ILE CYS GLY GLU ASN GLU ASN CYS SEQRES 5 A 143 PRO PRO GLY VAL GLY ALA CYS PHE GLY GLN THR ARG ILE SEQRES 6 A 143 SER VAL GLY LYS ALA ASN LYS ARG LEU ARG TYR VAL ASP SEQRES 7 A 143 GLN VAL LEU GLN LEU VAL TYR LYS ASP GLY SER PRO CYS SEQRES 8 A 143 PRO SER LYS SER GLY LEU SER TYR LYS SER VAL ILE SER SEQRES 9 A 143 PHE VAL CYS ARG PRO GLU ALA GLY PRO THR ASN ARG PRO SEQRES 10 A 143 MET LEU ILE SER LEU ASP LYS GLN THR CYS THR LEU PHE SEQRES 11 A 143 PHE SER TRP HIS THR PRO LEU ALA CYS GLU GLN ALA THR SEQRES 1 B 143 MET LYS SER ASN GLU HIS ASP ASP CYS GLN VAL THR ASN SEQRES 2 B 143 PRO SER THR GLY HIS LEU PHE ASP LEU SER SER LEU SER SEQRES 3 B 143 GLY ARG ALA GLY PHE THR ALA ALA TYR SER GLU LYS GLY SEQRES 4 B 143 LEU VAL TYR MET SER ILE CYS GLY GLU ASN GLU ASN CYS SEQRES 5 B 143 PRO PRO GLY VAL GLY ALA CYS PHE GLY GLN THR ARG ILE SEQRES 6 B 143 SER VAL GLY LYS ALA ASN LYS ARG LEU ARG TYR VAL ASP SEQRES 7 B 143 GLN VAL LEU GLN LEU VAL TYR LYS ASP GLY SER PRO CYS SEQRES 8 B 143 PRO SER LYS SER GLY LEU SER TYR LYS SER VAL ILE SER SEQRES 9 B 143 PHE VAL CYS ARG PRO GLU ALA GLY PRO THR ASN ARG PRO SEQRES 10 B 143 MET LEU ILE SER LEU ASP LYS GLN THR CYS THR LEU PHE SEQRES 11 B 143 PHE SER TRP HIS THR PRO LEU ALA CYS GLU GLN ALA THR HET BR A1141 1 HET BR A1142 1 HET BR A1143 1 HET BR A1144 1 HET BR B1141 1 HET BR B1142 1 HET BR B1143 1 HET BR B1144 1 HET BR B1145 1 HET BR B1146 1 HETNAM BR BROMIDE ION FORMUL 3 BR 10(BR 1-) FORMUL 13 HOH *145(H2 O) HELIX 1 1 SER A 23 SER A 26 5 4 HELIX 2 2 PRO A 136 CYS A 139 5 4 HELIX 3 3 SER B 23 LEU B 25 5 3 HELIX 4 4 PRO B 136 CYS B 139 5 4 SHEET 1 AA 2 GLN A 10 THR A 12 0 SHEET 2 AA 2 LEU A 19 ASP A 21 -1 O PHE A 20 N VAL A 11 SHEET 1 AB 3 PHE A 31 TYR A 35 0 SHEET 2 AB 3 GLY A 39 MET A 43 -1 O GLY A 39 N TYR A 35 SHEET 3 AB 3 ALA A 58 PHE A 60 -1 O CYS A 59 N TYR A 42 SHEET 1 AC 5 ARG A 75 VAL A 77 0 SHEET 2 AC 5 VAL A 80 TYR A 85 -1 O VAL A 80 N VAL A 77 SHEET 3 AC 5 LYS A 100 CYS A 107 -1 O SER A 101 N TYR A 85 SHEET 4 AC 5 THR A 128 THR A 135 1 O LEU A 129 N VAL A 102 SHEET 5 AC 5 MET A 118 ASP A 123 -1 O MET A 118 N SER A 132 SHEET 1 BA 2 GLN B 10 THR B 12 0 SHEET 2 BA 2 LEU B 19 ASP B 21 -1 O PHE B 20 N VAL B 11 SHEET 1 BB 3 PHE B 31 TYR B 35 0 SHEET 2 BB 3 GLY B 39 MET B 43 -1 O GLY B 39 N TYR B 35 SHEET 3 BB 3 ALA B 58 PHE B 60 -1 O CYS B 59 N TYR B 42 SHEET 1 BC 5 ARG B 75 VAL B 77 0 SHEET 2 BC 5 VAL B 80 TYR B 85 -1 O VAL B 80 N VAL B 77 SHEET 3 BC 5 LYS B 100 CYS B 107 -1 O SER B 101 N TYR B 85 SHEET 4 BC 5 THR B 128 THR B 135 1 O LEU B 129 N VAL B 102 SHEET 5 BC 5 MET B 118 ASP B 123 -1 O MET B 118 N SER B 132 SSBOND 1 CYS A 9 CYS A 46 1555 1555 2.02 SSBOND 2 CYS A 52 CYS A 59 1555 1555 2.03 SSBOND 3 CYS A 91 CYS A 127 1555 1555 2.03 SSBOND 4 CYS A 107 CYS A 139 1555 1555 2.02 SSBOND 5 CYS B 9 CYS B 46 1555 1555 2.03 SSBOND 6 CYS B 52 CYS B 59 1555 1555 2.02 SSBOND 7 CYS B 91 CYS B 127 1555 1555 2.05 SSBOND 8 CYS B 107 CYS B 139 1555 1555 2.03 SITE 1 AC1 3 SER A 89 SER A 132 HIS A 134 SITE 1 AC2 4 TYR A 35 LEU A 40 GLY A 61 GLN A 62 SITE 1 AC3 2 ASP A 87 LYS A 100 SITE 1 AC4 1 LYS B 72 SITE 1 AC5 5 TYR B 35 LEU B 40 GLY B 61 GLN B 62 SITE 2 AC5 5 HOH B2051 SITE 1 AC6 3 SER B 132 HIS B 134 BR B1144 SITE 1 AC7 3 SER B 66 BR B1143 HOH B2030 SITE 1 AC8 1 LEU B 122 SITE 1 AC9 2 THR B 135 HOH B2062 CRYST1 102.426 49.060 74.380 90.00 129.01 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009763 0.000000 0.007909 0.00000 SCALE2 0.000000 0.020383 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017302 0.00000 MTRIX1 1 0.020570 -0.999790 -0.000140 7.67511 1 MTRIX2 1 -0.954560 -0.019600 -0.297360 20.07979 1 MTRIX3 1 0.297300 0.006250 -0.954760 21.65717 1